In March 2025, the company announced new programs to get a immediate-to-purchaser presenting of its Wegovy weight loss drug. The company recognized a new pharmacy, referred to as NovoCare, which might cost shoppers $499 per month for access to the drug, lower than half the cost of the drug via other pharmaceutical distribution networks.[fifty three